Emily Goldberg

Emily Goldberg is a leading researcher at the University of California San Francisco, focusing on immune-metabolic interactions in aging. Her work explores mechanisms underlying age-related inflammation (inflammaging) and its role in chronic diseases such as insulin resistance, cardiovascular disorders, and Alzheimer’s disease.

• B.S., Biochemistry & Molecular Biology, University of Arizona (2008)
• Ph.D., Nutritional Science & Immunology, University of Arizona (2014)
• Postdoc, Immunometabolism, Yale University (2020)

Her research integrates immunology and metabolism to identify strategies for healthspan extension, emphasizing ketone bodies, inflammasome regulation, and immune cell function in adipose tissue. She has pioneered studies on how metabolic pathways influence inflammatory responses during aging.

Goldberg’s recent publications highlight her focus on epigenetic mechanisms, lipid metabolism, and immunometabolic countermeasures against infections and atherosclerosis. These works span disciplines including immunology, gerontology, and metabolic disease research.

• 2020 Chan Zuckerberg Investigator Award
• 2018 Society for Leukocyte Biology Trainee Award
• 2016 American Heart Association Postdoctoral Fellowship
• 2015 American Federation for Aging Research Postdoctoral Fellowship

She has secured significant NIH funding (R00AG058801, K99AG058801) for projects on ketone bodies and age-related inflammation. Her collaborative work spans institutions and disciplines, addressing neurodegenerative diseases, diabetes, and immune senescence.